US National Institutes of Health (NIH) voluntary posting (" Public Access") policy

Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Exceptions: It is the policy of Elsevier that authors need not obtain permission in the following cases only: (1) to use their original figures or tables in their future works; (2) to make copies of their papers for use in their classroom teaching; and (3) to include their papers as part of their dissertations.

ONLINE SUBMISSION OF MANUSCRIPTS

Should authors considering the journal have any queries regarding submission, they can contact the Editor-in-Chief. His contact details are as follows: Professor Harry W.M. Steinbusch, Maastricht, The Netherlands cheneu@np.unimaas.nl Please note that all actual submissions must be made as shown in the submission sections below.


Only articles written in English will be considered. The Editor-in-Chief reserves the right to reject papers on ethical grounds.


All manuscripts should be submitted through Journal of Chemical Neuroanatomy's online submission and peer review website (http://ees.elsevier.com/cheneu)Authors are requested to submit the text, tables and artwork in electronic form. In a Cover letter, authors should state that the manuscript, or parts of it, have not been and will not be submitted elsewhere for publication.


Submission items include Cover letter, Keywords, Manuscript file (including Title page, Abstract, Manuscript text, References and Table/Figure legends), Tables and Figures. Files should be labelled with appropriate and descriptive file names (e.g. SmithText.doc,Fig1.eps).


Authors may input the names of suggested referees, together with their email addresses. Although Journal of Chemical Neuroanatomy does not garantee these reviewers will be used, the editor takes the suggestions into consideration.
Before submitting, it is essential that you refer to the Elsevier Artwork Guidelines: http://www.elsevier.com/authorartworkinstructions


Language Editing:

Prior to submission, authors for whom English is not their first language may find it helpful to use a language and copyediting service such as that available through http://www.elsevier.com.locate/languagepolishing or may contact authorsupport@elsevier.com for more information. Please note that Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our Terms & Conditions http://www.elsevier.com//termsconditions.

When human subjects are used, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject, with the approval of the appropriate local ethics committee, and in compliance with national legislation and the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (Declaration of Helsinki) http://www.wma.net/e/policy/b3.htm

When experimental animals are used, the materials and methods section must clearly indicate that adequate measures were taken to minimise pain or discomfort, and that the experiments were conducted in accordance with international standards on animal welfare as well as being compliant with local and national regulations. Studies are expected to be compliant with minimal standards as defined by the European Communities Council Directive of 24 November 1986 (86/609/EEC) http://europa.eu.int/comm/food/fs/aw/aw_legislation/scientific/86-609-e ec_en.pdf and the National Institutes of Health Guide for the Care and Use of Laboratory Animals http://www.nap.edu/readingroom/books/labrats/ Full details of any anaesthetic or analgesic dose and treatment must be given.

All manuscripts are expected to comply with contemporary standards of ethical practice in scientific publication, regarding such matters as study design and ethical approval, data probity and fabrication, authorship, declaration of conflict of interest, plagiarism and redundant publication.

STYLE AND PRESENTATION

1. All manuscripts should include a separate title sheet containing the title of the manuscript, the name of the author(s), institutional affiliation and full postal address, including telephone and, if available, fax number of the author to whom page proofs and correspondence should be dispatched. The title of the paper should be brief; no longer than 100 characters in length, and should capture and communicate the key message of your research to a broader audience. To aid this, abbreviations, unless familiar to a broad audience, should be avoided.
2. All manuscripts should be typed, using double line spacing (including references, tables and figure legends) on A4 (210 x 297 mm) or equivalent paper. Margins of at least 40 mm should be left at the top, bottom and left-hand side of each page. Each page should be numbered in sequence in the top right-hand corner, with the title page as page 1.
3. Every paper for publication must be preceded by an abstract of not more than 250 words, stating the principal results and conclusions.
This should be typed on a separate sheet. The abstract should be self-contained and sufficiently comprehensive to allow effective use by abstracting services.
The Introduction should provide an adequate background for the research being reported, followed by Materials and methods, Results, and Discussion sections. In lengthy manuscripts, these sections should be divided into smaller sections using subheadings.
4. KEYWORDS: A maximum of 7 keywords, identified as such, should appear below the abstract. Do not repeat words from the title, and refer to Index Medicus for examples of headings.
Nomenclature, abbreviations and symbols should be used consistently and follow the latest internationally accepted rules. As a general rule, all except standard abbreviations should be defined when first used.
5. REFERENCES. Only articles that have been published or are in press may be included in the references. References to published literature should be quoted in the text by giving the author's name and year of publication in parentheses. The two possible forms of this depend on the context. One can either discuss a specific piece of work: e.g. 'see Hökfelt (1982)', or references can be appended to a statement '(Hökfelt, 1982; Sawchenko, 1983)'. If two or more references are cited, they should be in chronological order. For 3 or more authors, the first author should be cited and et al. within the text. The full list of authors should then be given in the reference list.
References to a 'personal communication' should be made only in the text, with the permission of the person who communicated the information. A letter from the cited person giving permission for the citing of unpublished results must be included. Where a work is cited as being 'in press' this implies that it has been formally accepted for publication. Permission from the author to refer to this work must be obtained and the name of the journal which has accepted the paper should be cited in the reference. References should be listed alphabetically in a section labelled 'References' at the end of the paper. Journal references should be arranged as follows, using abbreviated journal names, and giving the first and last page:
Cuello, A.C., Kanazawa, L., 1978. The distribution of substance P immunoreactive fibers in the rat central nervous system. J. Comp. Neurol. 178, 129-156.
Book References should be given as follows:
Either: Bures, J., Buresova, O., Huston, J., 1983. Techniques and Basic Experiments for the Study of Brain and Behaviour, Elsevier, Amsterdam.
or: Rossier, J., Bloom, F., 1982. Central neuropharmacology of endorphins. In: Malick, J.B., Bell, R.M.S. (Eds.), Endorphins. Dekker, New York, pp. 165-186.
6. TABLES. These should be typed in double spacing, with adequate space between vertical and horizontal columns. The units in which the results are expressed should be given at the top of each column and not repeated in each line of the table. Tables should be numbered consecutively with Arabic numerals.
7. Figures: Figures must be self-explanatory, titled, cited in order in the text, and numbered consecutively with Arabic numerals. On separate pages, type figure titles with their (brief) legends. Figures should not be embedded in text. Several figures may be grouped into a plate on one page. Lettering on micrographs should be clearly legible. Letters 2 mm high are recommended. Limit the field of micrographs to structures specifically discussed in the report. Symbols and areas of special interest should not be close to the edges. Give figure magnification in the legends and on the figures (micrometer scale). Symbols (minimum 3 mm height) used on micrographs must be explained in the figure legends. For detailed artwork instructions, see http://www.elsevier.com/artworkinstructions

8.Colour Figures: If together with your accepted article, you submit usable colour figures, then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions [Please note: Because of technical complications that can arise in converting colour figures to "grey scale" (for the printed version should you not opt for colour in print), please submit in addition usable black-and-white files corresponding to all the colour illustrations].

Authors should note that a request to revert from full colour to colour only in the electronic publication at the stage of typesetting and proof correction, will require separate editorial agreement, with possible re-review if necessary, and may significantly delay publication of your manuscript.

9.Supplementary material: Electronic supplementary material is now accepted to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our Corporate Website at http://www.elsevier.com/authors.

GENERAL

1. Manuscripts will be returned if rejected, together with referees' comments.
2. Manuscripts returned for revision with referees' comments should be resubmitted within 3 months.


Copyright:

Upon acceptance of an article, authors will be asked to Transfer copyright. This transfer will ensure the widest possible dissemination of information. If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has pre-printed forms for use by authors in these cases: contact Elsevier Rights Department, P.O. Box 800, Oxford, OX5 1DX, UK, phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com. Requests may also be completed online via the Elsevier home page ( http://www.elsevier.com/locate/permissions).

PROOFS

Manuscripts will not be returned if accepted, but the publisher will supply proofs to the designated author prior to publication.
Proofs are provided primarily for checking typesetting accuracy. Any alterations from the edited manuscript will be subject to the publisher's discretion. No page charges will be levied against authors or their institutions for publication in this journal.


Offprints: The corresponding author, at no cost, will be provided with a pdf offprint. Should they wish, they may opt to receive 50 paper offprints instead. As a special bonus we can offer an author who submits an article for a second time 100 free offprints instead of the normal 50.


Authors are invited to consult the Editor-in-Chief if in doubt about any aspect of scope, format or content of a proposed manuscript.


WWW
Further information on the Journal of Chemical Neuroanatomy, and on forthcoming, current and previous issues, can be found on http://www-np.unimaas.nl/Cheneu.html

Author enquiries:

For enquiries relating to the submission of articles (including electronic submission where available) please visit this journal's EES page. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed, as well as copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication

Disclaimer:

Whilst every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors and their respective employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any inaccurate or misleading data, opinion or statement.